Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders DOI Creative Commons

Vishal Payyalot Vishal,

Jong‐Min Oh, Ahmed Khames

et al.

Pharmaceutics, Journal Year: 2021, Volume and Issue: 13(6), P. 850 - 850

Published: June 8, 2021

Six halogenated trimethoxy chalcone derivatives (CH1–CH6) were synthesized and spectrally characterized. The compounds further evaluated for their inhibitory potential against monoamine oxidases (MAOs) β-secretase (BACE-1). inhibited MAO-B more effectively than MAO-A, the 2′,3′,4′-methoxy moiety in CH4–CH6 was effective inhibition 2′,4′,6′-methoxy CH1–CH3. Compound CH5 most potently MAO-B, with an IC50 value of 0.46 µM, followed by CH4 (IC50 = 0.84 µM). In (CH4-CH6), order –Br > -Cl -F CH6 at para-position ring B chalcone. selective selectivity index (SI) values 15.1 31.3, respectively, over MAO-A. moderately BACE-1 13.6 19.8 respectively. When assessed cell viability studies on normal African Green Monkey kidney line (VERO) using MTT assays, it noted that both found to be safe, only a slightly toxic effect observed concentrations above 200 µg/mL. decreased reactive oxygen species (ROS) levels VERO cells treated H2O2, indicating retained protective effects antioxidant activities. All showed high blood brain barrier permeabilities analyzed parallel artificial membrane permeability assay (PAMPA). Molecular docking ADME prediction lead provided insights into rationale behind binding CNS drug likeness. From non-test mutagenicity cardiotoxicity studies, non-mutagenic non-/weak-cardiotoxic. These results suggest could considered candidates cure neurological dysfunctions.

Language: Английский

A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer’s disease agents: A review DOI
Shoaib Manzoor, Nasimul Hoda

European Journal of Medicinal Chemistry, Journal Year: 2020, Volume and Issue: 206, P. 112787 - 112787

Published: Sept. 1, 2020

Language: Английский

Citations

188

Anticancer Activity of Natural and Synthetic Chalcones DOI Open Access
Teodora Constantinescu, Claudiu N. Lungu

International Journal of Molecular Sciences, Journal Year: 2021, Volume and Issue: 22(21), P. 11306 - 11306

Published: Oct. 20, 2021

Cancer is a condition caused by many mechanisms (genetic, immune, oxidation, and inflammatory). Anticancer therapy aims to destroy or stop the growth of cancer cells. Resistance treatment theleading cause inefficiency current standard therapies. Targeted therapies are most effective due low number side effects resistance. Among small molecule natural compounds, flavonoids particular interest for theidentification new anticancer agents. Chalcones precursors all have biological activities. The activity chalcones ability these compounds act on targets. Natural chalcones, such as licochalcones, xanthohumol (XN), panduretin (PA), loncocarpine, been extensively studied modulated. Modification basic structure in order obtain with superior cytotoxic properties has performed modulating aromatic residues, replacing residues heterocycles, obtaining hybrid molecules. A huge chalcone derivatives diaryl ether, sulfonamide, amine obtained, their presence being favorable activity. amino group aminochalconesis always antitumor This why molecules different nitrogen hetercycles obtained. From these, azoles (imidazole, oxazoles, tetrazoles, thiazoles, 1,2,3-triazoles, 1,2,4-triazoles) importance identification

Language: Английский

Citations

124

Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress DOI
Zhipei Sang, Keren Wang, Jianghong Dong

et al.

European Journal of Medicinal Chemistry, Journal Year: 2022, Volume and Issue: 238, P. 114464 - 114464

Published: May 20, 2022

Language: Английский

Citations

88

The cellular model for Alzheimer's disease research: PC12 cells DOI Creative Commons

Danni Xie,

Ting Deng,

Zhenwei Zhai

et al.

Frontiers in Molecular Neuroscience, Journal Year: 2023, Volume and Issue: 15

Published: Jan. 4, 2023

Alzheimer's disease (AD) is a common age-related neurodegenerative characterized by progressive cognitive decline and irreversible memory impairment. Currently, several studies have failed to fully elucidate AD's cellular molecular mechanisms. For this purpose, research on related models may propose potential predictive for the drug development of AD. Therefore, many cells neuronal properties are widely used mimic pathological process AD, such as PC12, SH-SY5Y, N2a, especially PC12 pheochromocytoma cell line. Thus, review covers most systematic essay that study We depict source, culture condition, differentiation methods, transfection drugs inducing general approaches (evaluation methods metrics), in vitro parallel with cells.

Language: Английский

Citations

48

Development of novel rivastigmine derivatives as selective BuChE inhibitors for the treatment of AD DOI
Yuting Li, Qiyao Zhang, Xinxin Wang

et al.

Bioorganic Chemistry, Journal Year: 2025, Volume and Issue: 157, P. 108245 - 108245

Published: Feb. 6, 2025

Language: Английский

Citations

2

Multitarget Therapeutic Strategies for Alzheimer’s Disease: Review on Emerging Target Combinations DOI Creative Commons
Samuele Maramai, Mohamed Benchekroun, Moustafa T. Gabr

et al.

BioMed Research International, Journal Year: 2020, Volume and Issue: 2020, P. 1 - 27

Published: July 3, 2020

Neurodegenerative diseases represent nowadays one of the major health problems. Despite efforts made to unveil mechanism leading neurodegeneration, it is still not entirely clear what triggers this phenomenon and allows its progression. Nevertheless, accepted that neurodegeneration a consequence several detrimental processes, such as protein aggregation, oxidative stress, neuroinflammation, finally resulting in loss neuronal functions. Starting from these evidences, there has been wide search for novel agents able address more than single event at same time, so-called multitarget-directed ligands (MTDLs). These compounds originated combination different pharmacophoric elements which endowed them with ability interfere enzymatic and/or receptor systems, or exert neuroprotective effects by modulating proteins metal homeostasis. MTDLs have focus latest strategies discover new treatment Alzheimer’s disease (AD), considered most common form dementia characterized cognitive dysfunctions. This review aimed collecting interesting target combinations AD, detailed discussion on favorable vitro properties optimized structures already assessed vivo animal models dementia.

Language: Английский

Citations

90

Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors DOI
Paolo Guglielmi, Bijo Mathew, Daniela Secci

et al.

European Journal of Medicinal Chemistry, Journal Year: 2020, Volume and Issue: 205, P. 112650 - 112650

Published: July 23, 2020

Language: Английский

Citations

71

Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease DOI Creative Commons
Siew Lee Cheong,

Jian Kai Tiew,

Yi Hang Fong

et al.

Pharmaceuticals, Journal Year: 2022, Volume and Issue: 15(12), P. 1560 - 1560

Published: Dec. 14, 2022

Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by decreased synaptic transmission and cerebral atrophy with appearance of amyloid plaques neurofibrillary tangles. Cognitive, functional, behavioral alterations are commonly associated the disease. Different pathophysiological pathways AD have been proposed, some which interact influence one another. Current treatment for mainly involves use therapeutic agents to alleviate symptoms in patients. The conventional single-target approaches do not often cause desired effect due its multifactorial origin. Thus, multi-target strategies since undertaken, aim simultaneously target multiple targets involved development AD. In this review, we provide an overview pathogenesis current drug therapies Additionally, rationales examples drugs pharmacological actions against also discussed.

Language: Английский

Citations

46

A New, Extremely Sensitive, Turn-Off Optical Sensor Utilizing Schiff Base for Fast Detection of Cu(II) DOI Creative Commons
Lotfi M. Aroua, Reham Ali, Abuzar E. A. E. Albadri

et al.

Biosensors, Journal Year: 2023, Volume and Issue: 13(3), P. 359 - 359

Published: March 8, 2023

Throughout this research, a unique optical sensor for detecting one of the most dangerous heavy metal ions, Cu(II), was designed and developed. The (4-mercaptophenyl) iminomethylphenyl naphthalenyl carbamate (MNC) probe effectively prepared. Schiff base shows "turn-off" state with excellent sensitivity to Cu(II) ions. This innovative fluorescent chemosensor possesses distinctive features substantial Stocks shift (about 114 nm). In addition, MNC has remarkable selectivity relative other cations. Density functional theory (DFT) time-dependent DFT (TDDFT) theoretical calculations were performed examine chelation structures associated electronic properties in solution, results indicate that luminescence quenching complex is due ICT. Chelation-quenched fluorescence responsible internal charge transfer (ICT)-based sensing molecule 1:9 (v/v) DMSO-HEPES buffer (20 mM, pH = 7.4) Fluorescence UV-Vis absorption ions investigated. By utilizing solution containing several interference studied. outstanding sensitivity, as well low LOD (1.45 nM). Consequently, these enable it find copper across an actual narrow dynamic range (0-1.2 M Cu(II)). reversibility obtained by employing EDTA powerful chelating agent.

Language: Английский

Citations

27

Dual-Target Inhibitors Based on Acetylcholinesterase: Novel Agents for Alzheimer's Disease DOI
Xingyi Zhao,

Qiaoguan Hu,

Xiaoqian Wang

et al.

European Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 279, P. 116810 - 116810

Published: Sept. 4, 2024

Language: Английский

Citations

9